_id
69130158ccc777a4e85d7922
Ticker
IMNM
Name
Immunome Inc
Exchange
NASDAQ
Address
18702 North Creek Parkway, Bothell, WA, United States, 98011
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://immunome.com
Description
Immunome, Inc., a clinical-stage biotechnology company, develops targeted cancer therapies. The company's clinical asset comprises Varegacestat, a gamma secretase inhibitor that is in Phase 3 clinical trial for the treatment of desmoid tumors; and IM-1021, a receptor tyrosine kinase-like orphan receptor 1 antibody-drug conjugate (ADC), which is in Phase 1 clinical trial. Its preclinical assets include IM-3050, a fibroblast activation protein targeted radioligand therapy; and solid tumor ADC drug candidates, including IM-1617, IM-1340, and IM-1335. Immunome, Inc. was incorporated in 2006 and is based in Bothell, Washington.
Last Close
19.49
Volume
275395
Current Price
19.57
Change
0.41046690610570474
Last Updated
2025-12-01T09:18:30.718Z
Image
data:image/webp;base64,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
Ipo Date
2020-10-02T00:00:00.000Z
Market Cap
1689303424
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0
Sentiment Sources
1
Rating
4.7778
Target Price
24.7273
Strong Buy
7
Buy
2
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
49193000
Gross Profit
-49193000
Operating Expenses
10945000
Operating Income
-60138000
Interest Expense
-
Pretax Income
-57457000
Net Income
-57457000
Eps
-0.6532332047884563
Dividends Per Share
-
Shares Outstanding
91710277
Income Tax Expense
-
EBITDA
-56868000
Operating Margin
-
Total Other Income Expense Net
2681000
Cash
272639000
Short Term Investments
0
Receivables
-
Inventories
-
Total Current Assets
279924000
Property Plant Equipment
14688000
Total Assets
299377000
Payables
6147000
Short Term Debt
-
Long Term Debt
-
Total Liabilities
35458000
Equity
263919000
Depreciation
733000
Change In Working Capital
10333000
Cash From Operations
-40510000
Capital Expenditures
1116000
Cash From Investing
123884000
Cash From Financing
45389000
Net Change In Cash
128763000
PE
-
PB
6.522211272246409
ROE
-21.770694796509535
ROA
-19.19218911272409
FCF
-41626000
Fcf Percent
-
Piotroski FScore
1
Health Score
35
Deep Value Investing Score
3.5
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
4.8
Garp Investing Score
2.5
Growth Investing Score
1
Momentum Investing Score
3.5
Net Net Investing Score
2.5
Quality Investing Score
2.5
Value Investing Score
4.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
49193000
Quarters > 0 > income Statement > gross Profit
-49193000
Quarters > 0 > income Statement > operating Expenses
10945000
Quarters > 0 > income Statement > operating Income
-60138000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-57457000
Quarters > 0 > income Statement > net Income
-57457000
Quarters > 0 > income Statement > eps
-0.6532332047884563
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
87957868
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-56868000
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
2681000
Quarters > 0 > balance Sheet > cash
272639000
Quarters > 0 > balance Sheet > short Term Investments
0
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
279924000
Quarters > 0 > balance Sheet > property Plant Equipment
14688000
Quarters > 0 > balance Sheet > total Assets
299377000
Quarters > 0 > balance Sheet > payables
6147000
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
35458000
Quarters > 0 > balance Sheet > equity
263919000
Quarters > 0 > cash Flow > net Income
-57457000
Quarters > 0 > cash Flow > depreciation
733000
Quarters > 0 > cash Flow > change In Working Capital
10333000
Quarters > 0 > cash Flow > cash From Operations
-40510000
Quarters > 0 > cash Flow > capital Expenditures
1116000
Quarters > 0 > cash Flow > cash From Investing
123884000
Quarters > 0 > cash Flow > cash From Financing
45389000
Quarters > 0 > cash Flow > net Change In Cash
128763000
Quarters > 0 > ratios > PE
-0.6532332047884563
Quarters > 0 > ratios > PB
6.522211272246409
Quarters > 0 > ratios > ROE
-21.770694796509535
Quarters > 0 > ratios > ROA
-19.19218911272409
Quarters > 0 > ratios > FCF
-41626000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
35
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
4015000
Quarters > 1 > income Statement > cost Of Revenue
720000
Quarters > 1 > income Statement > gross Profit
3295000
Quarters > 1 > income Statement > operating Expenses
49773000
Quarters > 1 > income Statement > operating Income
-46478000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-43397000
Quarters > 1 > income Statement > net Income
-43397000
Quarters > 1 > income Statement > eps
-0.4987545101040513
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
87010742
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-45758000
Quarters > 1 > income Statement > operating Margin
-1157.6089663760897
Quarters > 1 > income Statement > total Other Income Expense Net
3081000
Quarters > 1 > balance Sheet > cash
143876000
Quarters > 1 > balance Sheet > short Term Investments
124160000
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
277432000
Quarters > 1 > balance Sheet > property Plant Equipment
14294000
Quarters > 1 > balance Sheet > total Assets
296290000
Quarters > 1 > balance Sheet > payables
4660000
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
27020000
Quarters > 1 > balance Sheet > equity
269270000
Quarters > 1 > cash Flow > net Income
-43397000
Quarters > 1 > cash Flow > depreciation
720000
Quarters > 1 > cash Flow > change In Working Capital
-11757000
Quarters > 1 > cash Flow > cash From Operations
-49401000
Quarters > 1 > cash Flow > capital Expenditures
905000
Quarters > 1 > cash Flow > cash From Investing
-64171000
Quarters > 1 > cash Flow > cash From Financing
-55000
Quarters > 1 > cash Flow > net Change In Cash
-113627000
Quarters > 1 > ratios > PE
-0.4987545101040513
Quarters > 1 > ratios > PB
6.3237650720095075
Quarters > 1 > ratios > ROE
-16.11653730456419
Quarters > 1 > ratios > ROA
-14.646798744473319
Quarters > 1 > ratios > FCF
-50306000
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-12.529514321295144
Quarters > 1 > health Score
26
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
2926000
Quarters > 2 > income Statement > cost Of Revenue
726000
Quarters > 2 > income Statement > gross Profit
2926000
Quarters > 2 > income Statement > operating Expenses
47562000
Quarters > 2 > income Statement > operating Income
-44636000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-41640000
Quarters > 2 > income Statement > net Income
-41640000
Quarters > 2 > income Statement > eps
-0.5243648706061681
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
79410354
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-43910000
Quarters > 2 > income Statement > operating Margin
-1525.4955570745044
Quarters > 2 > income Statement > total Other Income Expense Net
2996000
Quarters > 2 > balance Sheet > cash
257613000
Quarters > 2 > balance Sheet > short Term Investments
59710000
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
323130000
Quarters > 2 > balance Sheet > property Plant Equipment
15116000
Quarters > 2 > balance Sheet > total Assets
342693000
Quarters > 2 > balance Sheet > payables
9126000
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
35567000
Quarters > 2 > balance Sheet > equity
307126000
Quarters > 2 > cash Flow > net Income
-41640000
Quarters > 2 > cash Flow > depreciation
726000
Quarters > 2 > cash Flow > change In Working Capital
-17026000
Quarters > 2 > cash Flow > cash From Operations
-53055000
Quarters > 2 > cash Flow > capital Expenditures
3665000
Quarters > 2 > cash Flow > cash From Investing
5089000
Quarters > 2 > cash Flow > cash From Financing
162228000
Quarters > 2 > cash Flow > net Change In Cash
114262000
Quarters > 2 > ratios > PE
-0.5243648706061681
Quarters > 2 > ratios > PB
5.060009988669146
Quarters > 2 > ratios > ROE
-13.5579534132571
Quarters > 2 > ratios > ROA
-12.150817203736288
Quarters > 2 > ratios > FCF
-56720000
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-19.384825700615174
Quarters > 2 > health Score
29
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
2738000
Quarters > 3 > income Statement > cost Of Revenue
595000
Quarters > 3 > income Statement > gross Profit
2738000
Quarters > 3 > income Statement > operating Expenses
85708000
Quarters > 3 > income Statement > operating Income
-82970000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-80249000
Quarters > 3 > income Statement > net Income
-80249000
Quarters > 3 > income Statement > eps
-1.2798069762294382
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
62703987
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-55003000
Quarters > 3 > income Statement > operating Margin
-3030.3140978816655
Quarters > 3 > income Statement > total Other Income Expense Net
2721000
Quarters > 3 > balance Sheet > cash
143351000
Quarters > 3 > balance Sheet > short Term Investments
73952000
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
221339000
Quarters > 3 > balance Sheet > property Plant Equipment
14391000
Quarters > 3 > balance Sheet > total Assets
240241000
Quarters > 3 > balance Sheet > payables
14189000
Quarters > 3 > balance Sheet > short Term Debt
63000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
59076000
Quarters > 3 > balance Sheet > equity
181165000
Quarters > 3 > cash Flow > net Income
-80249000
Quarters > 3 > cash Flow > depreciation
595000
Quarters > 3 > cash Flow > change In Working Capital
5288000
Quarters > 3 > cash Flow > cash From Operations
-42060000
Quarters > 3 > cash Flow > capital Expenditures
1375000
Quarters > 3 > cash Flow > cash From Investing
9758000
Quarters > 3 > cash Flow > cash From Financing
20085000
Quarters > 3 > cash Flow > net Change In Cash
-12217000
Quarters > 3 > ratios > PE
-1.2798069762294382
Quarters > 3 > ratios > PB
6.773477358154169
Quarters > 3 > ratios > ROE
-44.29608368062264
Quarters > 3 > ratios > ROA
-33.403540611302816
Quarters > 3 > ratios > FCF
-43435000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-15.863769174579986
Quarters > 3 > health Score
27
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
9041000
Annuals > 0 > income Statement > cost Of Revenue
2102000
Annuals > 0 > income Statement > gross Profit
9041000
Annuals > 0 > income Statement > operating Expenses
314841000
Annuals > 0 > income Statement > operating Income
-305800000
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-292963000
Annuals > 0 > income Statement > net Income
-292963000
Annuals > 0 > income Statement > eps
-4.996006015814509
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
58639441
Annuals > 0 > income Statement > income Tax Expense
-292963000
Annuals > 0 > income Statement > EBITDA
-151354000
Annuals > 0 > income Statement > operating Margin
-3382.3692069461345
Annuals > 0 > income Statement > total Other Income Expense Net
12837000
Annuals > 0 > balance Sheet > cash
143351000
Annuals > 0 > balance Sheet > short Term Investments
73952000
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
221339000
Annuals > 0 > balance Sheet > property Plant Equipment
14391000
Annuals > 0 > balance Sheet > total Assets
240241000
Annuals > 0 > balance Sheet > payables
14189000
Annuals > 0 > balance Sheet > short Term Debt
63000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
59076000
Annuals > 0 > balance Sheet > equity
181165000
Annuals > 0 > cash Flow > net Income
-292963000
Annuals > 0 > cash Flow > depreciation
2102000
Annuals > 0 > cash Flow > change In Working Capital
14874000
Annuals > 0 > cash Flow > cash From Operations
-110794000
Annuals > 0 > cash Flow > capital Expenditures
53508000
Annuals > 0 > cash Flow > cash From Investing
-85063000
Annuals > 0 > cash Flow > cash From Financing
240529000
Annuals > 0 > cash Flow > net Change In Cash
44672000
Annuals > 0 > ratios > PE
-4.996006015814509
Annuals > 0 > ratios > PB
5.962180902602601
Annuals > 0 > ratios > ROE
-161.71059531366433
Annuals > 0 > ratios > ROA
-121.94546309747297
Annuals > 0 > ratios > FCF
-164302000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-18.172989713527265
Annuals > 0 > health Score
29
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
14018000
Annuals > 1 > income Statement > cost Of Revenue
728000
Annuals > 1 > income Statement > gross Profit
14018000
Annuals > 1 > income Statement > operating Expenses
123548000
Annuals > 1 > income Statement > operating Income
-109530000
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
-106806000
Annuals > 1 > income Statement > net Income
-106806000
Annuals > 1 > income Statement > eps
-5.382376458848223
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
19843651
Annuals > 1 > income Statement > income Tax Expense
560105
Annuals > 1 > income Statement > EBITDA
-28000000
Annuals > 1 > income Statement > operating Margin
-781.3525467256385
Annuals > 1 > income Statement > total Other Income Expense Net
2724000
Annuals > 1 > balance Sheet > cash
98679000
Annuals > 1 > balance Sheet > short Term Investments
39463000
Annuals > 1 > balance Sheet > receivables
289000
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
144703000
Annuals > 1 > balance Sheet > property Plant Equipment
3637000
Annuals > 1 > balance Sheet > total Assets
148540000
Annuals > 1 > balance Sheet > payables
3311000
Annuals > 1 > balance Sheet > short Term Debt
310000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
28658000
Annuals > 1 > balance Sheet > equity
119882000
Annuals > 1 > cash Flow > net Income
-106806000
Annuals > 1 > cash Flow > depreciation
728000
Annuals > 1 > cash Flow > change In Working Capital
11997000
Annuals > 1 > cash Flow > cash From Operations
-7568000
Annuals > 1 > cash Flow > capital Expenditures
831000
Annuals > 1 > cash Flow > cash From Investing
-30484000
Annuals > 1 > cash Flow > cash From Financing
116408000
Annuals > 1 > cash Flow > net Change In Cash
78356000
Annuals > 1 > ratios > PE
-5.382376458848223
Annuals > 1 > ratios > PB
3.0489986104669593
Annuals > 1 > ratios > ROE
-89.09260773093543
Annuals > 1 > ratios > ROA
-71.90386427898208
Annuals > 1 > ratios > FCF
-8399000
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-0.5991582251391069
Annuals > 1 > health Score
30
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
6627000
Annuals > 2 > income Statement > cost Of Revenue
631000
Annuals > 2 > income Statement > gross Profit
-631000
Annuals > 2 > income Statement > operating Expenses
36901000
Annuals > 2 > income Statement > operating Income
-36901000
Annuals > 2 > income Statement > interest Expense
5000
Annuals > 2 > income Statement > pretax Income
-36896000
Annuals > 2 > income Statement > net Income
-36896000
Annuals > 2 > income Statement > eps
-3.0425743530344476
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
12126573
Annuals > 2 > income Statement > income Tax Expense
617000
Annuals > 2 > income Statement > EBITDA
-36270000
Annuals > 2 > income Statement > operating Margin
-556.8281273577787
Annuals > 2 > income Statement > total Other Income Expense Net
5000
Annuals > 2 > balance Sheet > cash
20323000
Annuals > 2 > balance Sheet > short Term Investments
0
Annuals > 2 > balance Sheet > receivables
847000
Annuals > 2 > balance Sheet > inventories
-847000
Annuals > 2 > balance Sheet > total Current Assets
22649000
Annuals > 2 > balance Sheet > property Plant Equipment
965000
Annuals > 2 > balance Sheet > total Assets
24046000
Annuals > 2 > balance Sheet > payables
2400000
Annuals > 2 > balance Sheet > short Term Debt
229000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
7393000
Annuals > 2 > balance Sheet > equity
16653000
Annuals > 2 > cash Flow > net Income
-36896000
Annuals > 2 > cash Flow > depreciation
631000
Annuals > 2 > cash Flow > change In Working Capital
2243000
Annuals > 2 > cash Flow > cash From Operations
-28690000
Annuals > 2 > cash Flow > capital Expenditures
248000
Annuals > 2 > cash Flow > cash From Investing
-248000
Annuals > 2 > cash Flow > cash From Financing
32000
Annuals > 2 > cash Flow > net Change In Cash
-28906000
Annuals > 2 > ratios > PE
-3.0425743530344476
Annuals > 2 > ratios > PB
13.413287375247704
Annuals > 2 > ratios > ROE
-221.55767729538223
Annuals > 2 > ratios > ROA
-153.43924145388007
Annuals > 2 > ratios > FCF
-28938000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-4.366681756450883
Annuals > 2 > health Score
26
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
755000
Annuals > 3 > income Statement > gross Profit
-755000
Annuals > 3 > income Statement > operating Expenses
25204000
Annuals > 3 > income Statement > operating Income
-25204000
Annuals > 3 > income Statement > interest Expense
10000
Annuals > 3 > income Statement > pretax Income
-24711000
Annuals > 3 > income Statement > net Income
-24711000
Annuals > 3 > income Statement > eps
-2.1415816799651397
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
11538668
Annuals > 3 > income Statement > income Tax Expense
-242000
Annuals > 3 > income Statement > EBITDA
-24449000
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
493000
Annuals > 3 > balance Sheet > cash
49229000
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
4312000
Annuals > 3 > balance Sheet > inventories
-4312000
Annuals > 3 > balance Sheet > total Current Assets
56638000
Annuals > 3 > balance Sheet > property Plant Equipment
855000
Annuals > 3 > balance Sheet > total Assets
57925000
Annuals > 3 > balance Sheet > payables
3077000
Annuals > 3 > balance Sheet > short Term Debt
317000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
9740000
Annuals > 3 > balance Sheet > equity
48185000
Annuals > 3 > cash Flow > net Income
-24711000
Annuals > 3 > cash Flow > depreciation
755000
Annuals > 3 > cash Flow > change In Working Capital
2778000
Annuals > 3 > cash Flow > cash From Operations
-18226000
Annuals > 3 > cash Flow > capital Expenditures
79000
Annuals > 3 > cash Flow > cash From Investing
-79000
Annuals > 3 > cash Flow > cash From Financing
27768000
Annuals > 3 > cash Flow > net Change In Cash
9463000
Annuals > 3 > ratios > PE
-2.1415816799651397
Annuals > 3 > ratios > PB
4.410963257445264
Annuals > 3 > ratios > ROE
-51.28359447960984
Annuals > 3 > ratios > ROA
-42.66033664220976
Annuals > 3 > ratios > FCF
-18305000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
29
Valuation > metrics > PE
-0.6532332047884563
Valuation > metrics > PB
6.522211272246409
Valuation > final Score
20
Valuation > verdict
117.4% Overvalued
Profitability > metrics > ROE
-21.770694796509535
Profitability > metrics > ROA
-20.525928466297998
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.13435182764408776
Risk > metrics > Interest Coverage
-102.1018675721562
Risk > final Score
-348
Risk > verdict
High
Liquidity > metrics > Current Ratio
45.53831137140068
Liquidity > metrics > Quick Ratio
45.53831137140068
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
20
Prev Valuations > 1
29.399900113308544
Prev Valuations > 2
20
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
-19
Prev Risks > 1
-19
Prev Risks > 2
47
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-14T00:40:12.548Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-03-19
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
0
Earnings History > 0 > eps Estimate
-0.5399
Earnings History > 0 > eps Difference
0.5399
Earnings History > 0 > surprise Percent
100
Earnings History > 1 > period
2025-09-30
Earnings History > 1 > report Date
2025-11-17
Earnings History > 1 > date
2025-09-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.65
Earnings History > 1 > eps Estimate
-0.567
Earnings History > 1 > eps Difference
-0.083
Earnings History > 1 > surprise Percent
-14.6384
Earnings History > 2 > period
2025-06-30
Earnings History > 2 > report Date
2025-08-06
Earnings History > 2 > date
2025-06-30
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.5
Earnings History > 2 > eps Estimate
-0.6218
Earnings History > 2 > eps Difference
0.1218
Earnings History > 2 > surprise Percent
19.5883
Earnings History > 3 > period
2025-03-31
Earnings History > 3 > report Date
2025-05-12
Earnings History > 3 > date
2025-03-31
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-0.52
Earnings History > 3 > eps Estimate
-0.81
Earnings History > 3 > eps Difference
0.29
Earnings History > 3 > surprise Percent
35.8025
Earnings History > 4 > period
2024-12-31
Earnings History > 4 > report Date
2025-03-26
Earnings History > 4 > date
2024-12-31
Earnings History > 4 > before After Market
BeforeMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-1.11
Earnings History > 4 > eps Estimate
-0.6075
Earnings History > 4 > eps Difference
-0.5025
Earnings History > 4 > surprise Percent
-82.716
Earnings History > 5 > period
2024-09-30
Earnings History > 5 > report Date
2024-11-07
Earnings History > 5 > date
2024-09-30
Earnings History > 5 > before After Market
BeforeMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.78
Earnings History > 5 > eps Estimate
-0.56
Earnings History > 5 > eps Difference
-0.22
Earnings History > 5 > surprise Percent
-39.2857
Earnings History > 6 > period
2024-06-30
Earnings History > 6 > report Date
2024-08-09
Earnings History > 6 > date
2024-06-30
Earnings History > 6 > before After Market
BeforeMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.49
Earnings History > 6 > eps Estimate
-0.39
Earnings History > 6 > eps Difference
-0.1
Earnings History > 6 > surprise Percent
-25.641
Earnings History > 7 > period
2024-03-31
Earnings History > 7 > report Date
2024-05-14
Earnings History > 7 > date
2024-03-31
Earnings History > 7 > before After Market
BeforeMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-2.51
Earnings History > 7 > eps Estimate
-0.69
Earnings History > 7 > eps Difference
-1.82
Earnings History > 7 > surprise Percent
-263.7681
Earnings History > 8 > period
2023-12-31
Earnings History > 8 > report Date
2024-03-28
Earnings History > 8 > date
2023-12-31
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-4.22
Earnings History > 8 > eps Estimate
-0.28
Earnings History > 8 > eps Difference
-3.94
Earnings History > 8 > surprise Percent
-1407.1429
Earnings History > 9 > period
2023-09-30
Earnings History > 9 > report Date
2023-11-09
Earnings History > 9 > date
2023-09-30
Earnings History > 9 > before After Market
BeforeMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.36
Earnings History > 9 > eps Estimate
-0.17
Earnings History > 9 > eps Difference
-0.19
Earnings History > 9 > surprise Percent
-111.7647
Earnings History > 10 > period
2023-06-30
Earnings History > 10 > report Date
2023-08-09
Earnings History > 10 > date
2023-06-30
Earnings History > 10 > before After Market
BeforeMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.46
Earnings History > 10 > eps Estimate
-0.16
Earnings History > 10 > eps Difference
-0.3
Earnings History > 10 > surprise Percent
-187.5
Earnings History > 11 > period
2023-03-31
Earnings History > 11 > report Date
2023-05-05
Earnings History > 11 > date
2023-03-31
Earnings History > 11 > before After Market
BeforeMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.35
Earnings History > 11 > eps Estimate
0.59
Earnings History > 11 > eps Difference
-0.94
Earnings History > 11 > surprise Percent
-159.322
Earnings History > 12 > period
2022-12-31
Earnings History > 12 > report Date
2023-03-16
Earnings History > 12 > date
2022-12-31
Earnings History > 12 > before After Market
BeforeMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.64
Earnings History > 12 > eps Estimate
-0.67
Earnings History > 12 > eps Difference
0.03
Earnings History > 12 > surprise Percent
4.4776
Earnings History > 13 > period
2022-09-30
Earnings History > 13 > report Date
2022-11-14
Earnings History > 13 > date
2022-09-30
Earnings History > 13 > before After Market
BeforeMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.75
Earnings History > 13 > eps Estimate
-0.76
Earnings History > 13 > eps Difference
0.01
Earnings History > 13 > surprise Percent
1.3158
Earnings History > 14 > period
2022-06-30
Earnings History > 14 > report Date
2022-08-05
Earnings History > 14 > date
2022-06-30
Earnings History > 14 > before After Market
BeforeMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.74
Earnings History > 14 > eps Estimate
-0.75
Earnings History > 14 > eps Difference
0.01
Earnings History > 14 > surprise Percent
1.3333
Earnings History > 15 > period
2022-03-31
Earnings History > 15 > report Date
2022-05-12
Earnings History > 15 > date
2022-03-31
Earnings History > 15 > before After Market
BeforeMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.96
Earnings History > 15 > eps Estimate
-0.69
Earnings History > 15 > eps Difference
-0.27
Earnings History > 15 > surprise Percent
-39.1304
Earnings History > 16 > period
2021-12-31
Earnings History > 16 > report Date
2022-03-28
Earnings History > 16 > date
2021-12-31
Earnings History > 16 > before After Market
BeforeMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.68
Earnings History > 16 > eps Estimate
-0.81
Earnings History > 16 > eps Difference
0.13
Earnings History > 16 > surprise Percent
16.0494
Earnings History > 17 > period
2021-09-30
Earnings History > 17 > report Date
2021-11-15
Earnings History > 17 > date
2021-09-30
Earnings History > 17 > before After Market
AfterMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.65
Earnings History > 17 > eps Estimate
-0.5
Earnings History > 17 > eps Difference
-0.15
Earnings History > 17 > surprise Percent
-30
Earnings History > 18 > period
2021-06-30
Earnings History > 18 > report Date
2021-08-16
Earnings History > 18 > date
2021-06-30
Earnings History > 18 > before After Market
AfterMarket
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.46
Earnings History > 18 > eps Estimate
-0.39
Earnings History > 18 > eps Difference
-0.07
Earnings History > 18 > surprise Percent
-17.9487
Earnings History > 19 > period
2021-03-31
Earnings History > 19 > report Date
2021-05-12
Earnings History > 19 > date
2021-03-31
Earnings History > 19 > before After Market
BeforeMarket
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-0.37
Earnings History > 19 > eps Estimate
-0.41
Earnings History > 19 > eps Difference
0.04
Earnings History > 19 > surprise Percent
9.7561
Earnings History > 20 > period
2020-12-31
Earnings History > 20 > report Date
2021-03-25
Earnings History > 20 > date
2020-12-31
Earnings History > 20 > before After Market
AfterMarket
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-0.4
Earnings History > 20 > eps Estimate
-0.29
Earnings History > 20 > eps Difference
-0.11
Earnings History > 20 > surprise Percent
-37.931
Earnings History > 21 > period
2020-09-30
Earnings History > 21 > report Date
2020-11-16
Earnings History > 21 > date
2020-09-30
Earnings History > 21 > before After Market
AfterMarket
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-7.52
Earnings History > 21 > eps Estimate
-0.38
Earnings History > 21 > eps Difference
-7.14
Earnings History > 21 > surprise Percent
-1878.9474
Earnings History > 22 > period
2020-06-30
Earnings History > 22 > report Date
2020-09-02
Earnings History > 22 > date
2020-06-30
Earnings History > 22 > before After Market
-
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
-0.58
Earnings History > 22 > eps Estimate
0
Earnings History > 22 > eps Difference
-0.58
Earnings History > 22 > surprise Percent
-
Immunome, Inc., a clinical-stage biotechnology company, develops targeted cancer therapies. The company's clinical asset comprises Varegacestat, a gamma secretase inhibitor that is in Phase 3 clinical trial for the treatment of desmoid tumors; and IM-1021, a receptor tyrosine kinase-like orphan receptor 1 antibody-drug conjugate (ADC), which is in Phase 1 clinical trial. Its preclinical assets include IM-3050, a fibroblast activation protein targeted radioligand therapy; and solid tumor ADC drug candidates, including IM-1617, IM-1340, and IM-1335. Immunome, Inc. was incorporated in 2006 and is based in Bothell, Washington.
Stock Price
$ 0.00
0% increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AImmunome (IMNM) Is Up 15.3% After Desmoid Tumor Phase 3 Win and NDA Timeline Update – Has The Bull Case Changed? simplywall.st
Read more →Why Immunome Stock Surged Today - Finviz
12/15/2025
Why Immunome Stock Surged Today Finviz
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
STRONG BUY
Target Price:
$24.7273
Analyst Picks
Strong Buy
7
Buy
2
Hold
0
Sell
0
Strong Sell
0
Sentiment:
Neutral
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 113.76% of the total shares of Immunome Inc
1.
T. Rowe Price Investment Management,Inc.(9.5069%)
since
2025/06/30
2.
FMR Inc(7.0856%)
since
2025/06/30
3.
BlackRock Inc(6.6295%)
since
2025/06/30
4.
Redmile Group, LLC(5.5974%)
since
2025/06/30
5.
Enavate Sciences GP, LLC(5.4783%)
since
2025/06/30
6.
Point72 Asset Management, L.P.(5.3832%)
since
2025/06/30
7.
Vanguard Group Inc(5.1984%)
since
2025/06/30
8.
EcoR1 Capital, LLC(4.6866%)
since
2025/06/30
9.
Opaleye Management Inc(4.0549%)
since
2025/06/30
10.
Fidelity Growth Compy Commingled Pl S(3.8974%)
since
2025/07/31
11.
T. Rowe Price Small-Cap Stock(3.5828%)
since
2025/07/31
12.
T. Rowe Price US Small-Cap Core Equity(3.4861%)
since
2025/06/30
13.
PRIMECAP Management Company(3.4697%)
since
2025/06/30
14.
T. Rowe Price Associates, Inc.(3.4259%)
since
2025/06/30
15.
PRIMECAP Odyssey Aggressive Growth(3.0742%)
since
2025/06/30
16.
State Street Corp(2.8961%)
since
2025/06/30
17.
Fidelity Growth Company Fund(2.7374%)
since
2025/07/31
18.
Vanguard Total Stock Mkt Idx Inv(2.5203%)
since
2025/07/31
19.
T. Rowe Price Health Sciences(2.4844%)
since
2025/07/31
20.
The Toronto-Dominion Bank(2.3961%)
since
2025/06/30
21.
Jefferies Financial Group Inc(2.3961%)
since
2025/06/30
22.
Geode Capital Management, LLC(2.1375%)
since
2025/06/30
23.
iShares Russell 2000 ETF(2.0459%)
since
2025/08/31
24.
Woodline Partners LP(1.9055%)
since
2025/06/30
25.
T. Rowe Price Instl Small-Cap Stock(1.8083%)
since
2025/07/31
26.
T. Rowe Price U.S. SC Core Eq Tr-D(1.7067%)
since
2025/06/30
27.
Readystate Asset Management LP(1.555%)
since
2025/06/30
28.
Marshall Wace Asset Management Ltd(1.4909%)
since
2025/06/30
29.
HHG PLC(1.1953%)
since
2025/06/30
30.
Polar Capital Holdings PLC(1.1488%)
since
2025/06/30
31.
Polar Capital Biotech S Inc(1.1488%)
since
2025/07/31
32.
SPDR® S&P Biotech ETF(1.0694%)
since
2025/08/31
33.
T. Rowe Price Small-Cap Value(1.0601%)
since
2025/07/31
34.
Vanguard Institutional Extnd Mkt Idx Tr(1.0124%)
since
2025/07/31
35.
Fidelity Small Cap Index(0.8499%)
since
2025/06/30
36.
Fidelity Growth Company K6(0.8404%)
since
2025/07/31
37.
Fidelity Series Growth Company(0.7716%)
since
2025/07/31
38.
iShares Russell 2000 Growth ETF(0.7373%)
since
2025/08/31
39.
Fidelity Select Biotechnology(0.6715%)
since
2025/07/31
40.
T. Rowe Price U.S. SC Value Eq Tr-D(0.6163%)
since
2025/06/30
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
-0.5399
Date
2025-09-30
EPS Actual
-0.65
EPS Estimate
-0.567
EPS Difference
-0.083
Surprise Percent
-14.6384%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.